Jacobi Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4M | Sell |
7,649
-187
| -2% | -$34.5K | 0.08% | 236 |
|
|
2025
Q4 | $1.38M | Sell |
7,836
-289
| -4% | -$47.2K | 0.08% | 237 |
|
|
2025
Q3 | $1.14M | Buy |
8,125
+162
| +2% | +$21.9K | 0.07% | 261 |
|
|
2025
Q2 | $1M | Buy |
7,963
+1,952
| +32% | +$243K | 0.07% | 270 |
|
|
2025
Q1 | $823K | Buy |
6,011
+2,064
| +52% | +$295K | 0.06% | 281 |
|
|
2024
Q4 | $604K | Buy |
3,947
+1,132
| +40% | +$191K | 0.05% | 312 |
|
|
2024
Q3 | $546K | Buy |
2,815
+959
| +52% | +$201K | 0.04% | 329 |
|
|
2024
Q2 | $430K | Buy |
1,856
+192
| +12% | +$41.7K | 0.04% | 343 |
|
|
2024
Q1 | $359K | Buy |
1,664
+55
| +3% | +$12.9K | 0.03% | 358 |
|
|
2023
Q4 | $416K | Sell |
1,609
-200
| -11% | -$49.1K | 0.04% | 324 |
|
|
2023
Q3 | $465K | Buy |
1,809
+352
| +24% | +$94.1K | 0.05% | 283 |
|
|
2023
Q2 | $415K | Hold |
1,457
| – | – | 0.05% | 305 |
|
|
2023
Q1 | $405K | Hold |
1,457
| – | – | 0.05% | 301 |
|
|
2022
Q4 | $403K | Buy |
1,457
+59
| +4% | +$16.7K | 0.05% | 296 |
|
|
2022
Q3 | $373K | Sell |
1,398
-5
| -0.4% | -$1.06K | 0.05% | 290 |
|
|
2022
Q2 | $286K | Sell |
1,403
-184
| -12% | -$37.6K | 0.04% | 339 |
|
|
2022
Q1 | $334K | Hold |
1,587
| – | – | 0.04% | 325 |
|
|
2021
Q4 | $381K | Hold |
1,587
| – | – | 0.05% | 318 |
|
|
2021
Q3 | $449K | Hold |
1,587
| – | – | 0.06% | 272 |
|
|
2021
Q2 | $550K | Sell |
1,587
-240
| -13% | -$72.7K | 0.07% | 222 |
|
|
2021
Q1 | $511K | Hold |
1,827
| – | – | 0.08% | 219 |
|
|
2020
Q4 | $447K | Sell |
1,827
-33
| -2% | -$8.51K | 0.07% | 221 |
|
|
2020
Q3 | $528K | Hold |
1,860
| – | – | 0.09% | 175 |
|
|
2020
Q2 | $498K | Buy |
1,860
+42
| +2% | +$12.6K | 0.09% | 172 |
|
|
2020
Q1 | $575K | Buy |
1,818
+142
| +8% | +$43.1K | 0.12% | 138 |
|
|
2019
Q4 | $497K | Buy |
1,676
+55
| +3% | +$15.3K | 0.09% | 182 |
|
|
2019
Q3 | $377K | Sell |
1,621
-50
| -3% | -$11.6K | 0.07% | 210 |
|
|
2019
Q2 | $391K | Sell |
1,671
-10
| -0.6% | -$2.31K | 0.08% | 201 |
|
|
2019
Q1 | $397K | Sell |
1,681
-282
| -14% | -$88.8K | 0.1% | 148 |
|
|
2018
Q4 | $591K | Sell |
1,963
-313
| -14% | -$99.9K | 0.16% | 98 |
|
|
2018
Q3 | $804K | Buy |
2,276
+178
| +8% | +$61.3K | 0.21% | 64 |
|
|
2018
Q2 | $609K | Buy |
2,098
+118
| +6% | +$33.2K | 0.18% | 81 |
|
|
2018
Q1 | $528K | Buy |
1,980
+95
| +5% | +$29.5K | 0.16% | 82 |
|
|
2017
Q4 | $621K | Buy |
1,885
+191
| +11% | +$61.3K | 0.2% | 74 |
|
|
2017
Q3 | $557K | Buy |
1,694
+85
| +5% | +$25.2K | 0.19% | 72 |
|
|
2017
Q2 | $440K | Buy |
1,609
+50
| +3% | +$13.2K | 0.17% | 69 |
|
|
2017
Q1 | $422K | Buy |
1,559
+29
| +2% | +$8.2K | 0.22% | 60 |
|
|
2016
Q4 | $439K | Sell |
1,530
-29
| -2% | -$8.6K | 0.27% | 51 |
|
|
2016
Q3 | $486K | Buy |
1,559
+30
| +2% | +$8.88K | 0.23% | 50 |
|
|
2016
Q2 | $378K | Buy |
+1,529
| New | +$403K | 0.19% | 55 |
|
Other funds holding BIIB
VCM
VPM
Jacobi Capital Management's BIIB Position: Q1 2026 in Review
Jacobi Capital Management reduced its Biogen (BIIB) stake by 2.4% in Q1 2026, selling an estimated $34.5K and leaving 7,649 shares worth $1.4M. The position accounts for 0.08% of the portfolio, ranked #236.
Jacobi Capital Management first reported a position in BIIB in Q2 2016 and has held it in 40 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Jacobi Capital Management held 7,649 shares of Biogen worth $1.4M as of Q1 2026.
- Jacobi Capital Management sold 187 Biogen shares in Q1 2026, an estimated $34.5K.
- Biogen made up 0.08% of Jacobi Capital Management's portfolio in Q1 2026, its #236 holding.
- Jacobi Capital Management first reported a position in Biogen in Q2 2016 and has held it in 40 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Jacobi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.